Serum concentrations of lamotrigine in epileptic patients: the influence of dose and comedication
- PMID: 8885114
- DOI: 10.1097/00007691-199610000-00001
Serum concentrations of lamotrigine in epileptic patients: the influence of dose and comedication
Abstract
Lamotrigine (LTG) is a new antiepileptic drug (AED), chemically unrelated to the drugs in current use. Previous studies have shown that LTG has only a limited effect on other AEDs, but its own metabolism can be strongly induced or inhibited by the comedication. We investigated the influences of carbamazepine (CBZ), phenytoin (PHT), phenobarbital (PB), valproic acid (VPA), and combinations of these drugs on the serum concentration of LTG. A total of 588 blood samples from 302 patients were analyzed. The mean duration of LTG therapy was 141 +/- 137 days (mean +/- SD). A patient was only considered twice in this study if his or her comedication had been changed. The LTG serum concentration in relation to LTG dose/body weight (level-to-dose ratio, LDR, microgram/ml/mg/kg) was calculated and compared for different drug combinations. The results showed that comedication had a highly significant (p < 0.001) influence on the LTG serum concentrations. The mean LDR for LTG was 0.32 (LTG + PHT) < 0.52 (LTG + PB) approximately equal to 0.57 (LTG + CBZ) < 0.98 (LTG mono) approximately equal to 0.99 (LTG + VPA + PHT) < 1.67 (LTG + VPA + CBZ) approximately equal to 1.80 (LTG + VPA + PB) < 3.57 (LTG + VPA (<, p < 0.05; approximately equal to, p > 0.05, multiple comparisons). The mean LTG concentrations in patients on comedication with VPA were about two times higher than on patients on LTG monotherapy or on comedication without VPA (5.0 vs. 2.6 micrograms/ml), despite the LTG doses being half as high (3.0 vs. 5.9 mg/kg). The correlations of the serum concentrations and doses of CBZ, PB, PHT, and VPA with the LDR of LTG were only weak or not significant. Furthermore, the distribution of LTG serum concentrations and dosages was compared with the tentative therapeutic range for the LTG concentration (1-4 micrograms/ml), proposed by some investigators, and the recommendations for the LTG dosage. Remarkable discrepancies were observed. The comedication has an important influence on the LTG concentration and should be considered in LTG dosage.
Similar articles
-
Influence of oxcarbazepine and methsuximide on lamotrigine concentrations in epileptic patients with and without valproic acid comedication: results of a retrospective study.Ther Drug Monit. 1999 Apr;21(2):175-81. doi: 10.1097/00007691-199904000-00007. Ther Drug Monit. 1999. PMID: 10217337
-
Does lamotrigine influence valproate concentrations?Ther Drug Monit. 2002 Oct;24(5):631-6. doi: 10.1097/00007691-200210000-00009. Ther Drug Monit. 2002. PMID: 12352935
-
The effects of co-medications on lamotrigine clearance in Japanese children with epilepsy.Brain Dev. 2016 Sep;38(8):723-30. doi: 10.1016/j.braindev.2016.03.004. Epub 2016 Mar 28. Brain Dev. 2016. PMID: 27033151
-
[Influence of coadministered antiepileptic drugs on serum antiepileptic drug concentrations in epileptic patients -quantitative analysis based on suitable transforming factor].Yakugaku Zasshi. 2004 Jul;124(7):443-50. doi: 10.1248/yakushi.124.443. Yakugaku Zasshi. 2004. PMID: 15235228 Review. Japanese.
-
Correlating lamotrigine serum concentrations with tolerability in patients with epilepsy.Neurology. 2004 Sep 28;63(6):1022-6. doi: 10.1212/01.wnl.0000138424.33979.0c. Neurology. 2004. PMID: 15452293 Review.
Cited by
-
Clinically relevant drug interactions with antiepileptic drugs.Br J Clin Pharmacol. 2006 Mar;61(3):246-55. doi: 10.1111/j.1365-2125.2005.02529.x. Br J Clin Pharmacol. 2006. PMID: 16487217 Free PMC article. Review.
-
Lamotrigine pharmacokinetic evaluation in epileptic patients submitted to VEEG monitoring.Eur J Clin Pharmacol. 2006 Sep;62(9):737-42. doi: 10.1007/s00228-006-0144-9. Epub 2006 Jul 27. Eur J Clin Pharmacol. 2006. PMID: 16871388
-
Case report: Progressive skin rash and lymphadenopathy associated with lamotrigine-valproic acid combination in a bipolar adolescent.Front Pharmacol. 2023 Mar 17;14:1106423. doi: 10.3389/fphar.2023.1106423. eCollection 2023. Front Pharmacol. 2023. PMID: 37006998 Free PMC article.
-
Expression of UDP-glucuronosyltransferase 1A4 in human placenta at term.Eur J Drug Metab Pharmacokinet. 2011 Jan;35(3-4):79-82. doi: 10.1007/s13318-010-0021-x. Epub 2010 Dec 30. Eur J Drug Metab Pharmacokinet. 2011. PMID: 21302032 Free PMC article.
-
Development of a PBPK Model for Lamotrigine which Incorporates Metabolism by UGT2B10: Impact of UGT2B10 Poor Metabolizer Phenotype and Pregnancy.AAPS J. 2025 Feb 4;27(1):40. doi: 10.1208/s12248-025-01025-w. AAPS J. 2025. PMID: 39904839
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical